2 assets in Helicobacter Pylori Infection, Susceptibility To

Therapeutic assets addressing Helicobacter Pylori Infection, Susceptibility To, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Orelabrutinib Helicobacter Pylori Infection, Susceptibility To	Fudan University	P2	CCC (53)
Huazhi Rougan Granule Helicobacter Pylori Infection, Susceptibility To	Nanjing First Hospital, Nanjing Medical University	N/A	D (30)